Clinical Trial: A Seamless, Adaptive Multiple-Ascending-Dose and Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07680166) titled 'A Seamless, Adaptive Multiple-Ascending-Dose and Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations' on June 25.

Brief Summary: A study of XTMAB-16 in patients with pulmonary sarcoidosis

Study Start Date: Oct. 30, 2026

Study Type: INTERVENTIONAL

Condition: Pulmonary Sarcoidosis

Intervention: DRUG: XTMAB-16

Infusion

DRUG: Placebo

Infusion

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Xentria, Inc.

Disclaimer: Curated by HT Syndication....